1. To appreciate the extent of potentially beneficial and harmful systemic effects of “focal” interventional oncologic therapy.
2. To gain awareness of the molecular mechanisms that cause such systemic effects with an eye toward potentiating them for clinical benefit.
3. To learn how immuno-oncologic techniques can be combined with both percutaneous and transcatheter interventional oncologic therapies to potentially achieve better clinical outcomes.